Stevanato group announces voting results from its extraordinary general meeting

Piombino dese, italy--(business wire)--stevanato group s.p.a. (nyse: stvn), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries announced today that the resolution proposed to shareholders at the extraordinary general meeting of shareholders (“egm”) held virtually on october 4, 2023 was passed. details of the resolution submitted to, and approved by, the egm are included in the explanatory report.
STVN Ratings Summary
STVN Quant Ranking